Vanguard Group Inc Omega Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,097,106 shares of OMGA stock, worth $175,536. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,097,106
Previous 1,114,731
1.58%
Holding current value
$175,536
Previous $1.36 Million
39.51%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OMGA
# of Institutions
55Shares Held
42.6MCall Options Held
24.6KPut Options Held
5.8K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$4.68 Million6.56% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$561,9372.79% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$297,1620.0% of portfolio
-
Siren, L.L.C. New York, NY1.32MShares$211,7640.04% of portfolio
-
Chi Advisors LLC New York, NY1.06MShares$168,9411.12% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $7.66M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...